| Non‐pharmacological approaches for dementia that informal carers might try or access: a systematic review C Hulme, J Wright, T Crocker, Y Oluboyede, A House International journal of geriatric psychiatry 25 (7), 756-763, 2010 | 189 | 2010 |
| What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical … C Czoski-Murray, ML Jones, C McCabe, K Claxton, Y Oluboyede, ... Health technology assessment (Winchester, England) 16 (50), i, 2012 | 129 | 2012 |
| Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial H Fisher, Y Oluboyede, T Chadwick, M Abdel-Fattah, C Brennand, ... The Lancet infectious diseases 18 (9), 957-968, 2018 | 110 | 2018 |
| Effectiveness and acceptability of parental financial incentives and quasi-mandatory schemes for increasing uptake of vaccinations in preschool children: systematic review … J Adams, B Bateman, F Becker, T Cresswell, D Flynn, R McNaughton, ... Health technology assessment 19 (94), 1-176, 2015 | 100 | 2015 |
| A randomised 2 x 2 trial of community versus hospital pulmonary rehabilitation, followed by telephone or conventional follow-up. JC Waterhouse, SJ Walters, Y Oluboyede, RA Lawson Health technology assessment (Winchester, England) 14 (6), i-v, vii, 2010 | 79 | 2010 |
| Updated cost-effectiveness analysis of trastuzumab for early breast cancer: a UK perspective considering duration of benefit, long-term toxicity and pattern of recurrence PS Hall, C Hulme, C McCabe, Y Oluboyede, J Round, DA Cameron Pharmacoeconomics 29, 415-432, 2011 | 74 | 2011 |
| Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta … FE Mózes, JA Lee, Y Vali, O Alzoubi, K Staufer, M Trauner, R Paternostro, ... The Lancet Gastroenterology & Hepatology 8 (8), 704-713, 2023 | 46 | 2023 |
| Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis L McSweeney, M Breckons, G Fattakhova, Y Oluboyede, L Vale, ... JHEP Reports 2 (3), 100099, 2020 | 41 | 2020 |
| Cost effectiveness of chest pain unit care in the NHS Y Oluboyede, S Goodacre, A Wailoo, ... BMC Health Services Research 8, 1-9, 2008 | 40 | 2008 |
| The factor structure of the GHQ-12: the interaction between item phrasing, variance and levels of distress AB Smith, Y Oluboyede, R West, J Hewison, AO House Quality of Life Research 22, 145-152, 2013 | 37 | 2013 |
| Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCT R Pickard, T Chadwick, Y Oluboyede, C Brennand, ... Health Technology Assessment, 2018 | 34 | 2018 |
| A randomised 2× 2 trial of community versus hospital pulmonary rehabilitation for chronic obstructive pulmonary disease followed by telephone or conventional follow-up JC Waterhouse, SJ Walters, Y Oluboyede, RA Lawson Health Technol Assess 14 (6), 1-164, 2010 | 27 | 2010 |
| Economic evaluations of alcohol prevention interventions: Is the evidence sufficient? A review of methodological challenges SR Hill, L Vale, D Hunter, E Henderson, Y Oluboyede Health Policy 121 (12), 1249-1262, 2017 | 24 | 2017 |
| Development and refinement of the WAItE: a new obesity-specific quality of life measure for adolescents Y Oluboyede, C Hulme, A Hill Quality of Life Research 26, 2025-2039, 2017 | 19 | 2017 |
| Measuring health outcomes of adolescents: report from a pilot study Y Oluboyede, S Tubeuf, C McCabe The European Journal of Health Economics 14, 11-19, 2013 | 19 | 2013 |
| Measuring health-related quality of life in the general population and Roma communities in Romania: study protocol for two cross-sectional studies E Olariu, MS Paveliu, E Baican, Y Oluboyede, L Vale, IG Niculescu-Aron BMJ open 9 (8), e029067, 2019 | 15 | 2019 |
| Measuring weight-specific quality of life in adolescents: an examination of the concurrent validity and test-retest reliability of the WAItE Y Oluboyede, T Robinson Value in Health 22 (3), 348-354, 2019 | 14 | 2019 |
| Evidence for a unidimensional 15-item version of the CASP-19 using a Rasch model approach Y Oluboyede, AB Smith Quality of Life Research 22, 2429-2433, 2013 | 13 | 2013 |
| Nasal Airway Obstruction Study (NAIROS): a phase III, open-label, mixed-methods, multicentre randomised controlled trial of septoplasty versus medical management of a septal … KJ Rennie, J O’Hara, N Rousseau, D Stocken, D Howel, L Ternent, ... Trials 21, 1-14, 2020 | 12 | 2020 |
| Estimating CHU-9D utility scores from the WAItE: a mapping algorithm for economic evaluation T Robinson, Y Oluboyede Value in Health 22 (2), 239-246, 2019 | 11 | 2019 |
Professor Laura TernentNewcastle UniversityAdresă de e-mail confirmată pe ncl.ac.uk
